• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $NATR

    Nature's Sunshine Products Inc.

    Subscribe to $NATR
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. It also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. The company offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature's Sunshine Products, Inc. was founded in 1972 and is based in Lehi, Utah.

    IPO Year:

    Exchange: NASDAQ

    Website: naturessunshine.com

    Recent Analyst Ratings for Nature's Sunshine Products Inc.

    DatePrice TargetRatingAnalyst
    5/7/2025$19.00Buy
    DA Davidson
    9/13/2024$18.00Buy
    Canaccord Genuity
    3/9/2022$24.00 → $24.50Buy
    DA Davidson
    11/5/2021$22.00 → $24.00Buy
    DA Davidson
    10/15/2021$22.00Buy
    DA Davidson
    See more ratings

    Nature's Sunshine Products Inc. SEC Filings

    See more
    • SEC Form 10-Q filed by Nature's Sunshine Products Inc.

      10-Q - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      5/6/25 5:10:24 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      5/6/25 4:38:55 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form DEF 14A filed by Nature's Sunshine Products Inc.

      DEF 14A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      3/20/25 10:09:21 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-K filed by Nature's Sunshine Products Inc.

      10-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      3/11/25 5:13:03 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Products Inc. filed SEC Form 8-K: Leadership Update

      8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      2/5/25 4:04:50 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Nature's Sunshine Products Inc.

      10-Q - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      11/7/24 5:15:56 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

      8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      11/7/24 4:19:09 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Products Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      8/9/24 1:44:06 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Nature's Sunshine Products Inc.

      10-Q - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      8/8/24 5:10:08 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Nature's Sunshine Products Inc.

      10-Q - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

      5/7/24 5:11:08 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Nature's Sunshine Products Inc. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Fasching Steven J. was granted 8,000 shares, increasing direct ownership by 279% to 10,869 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/7/25 1:25:23 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Straus Robert D was granted 8,000 shares, increasing direct ownership by 18% to 52,014 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/6/25 3:42:40 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Roering Tess was granted 8,000 shares, increasing direct ownership by 36% to 29,927 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/6/25 3:42:30 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Kopf Curtis was granted 8,000 shares, increasing direct ownership by 36% to 29,927 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/6/25 3:42:19 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director May Katie was granted 8,000 shares, increasing direct ownership by 453% to 9,766 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/6/25 3:42:09 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Yang Rong was granted 8,000 shares, increasing direct ownership by 36% to 30,249 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/6/25 3:41:59 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Wissmiller Heidi was granted 8,000 shares, increasing direct ownership by 27% to 37,167 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      5/6/25 3:41:48 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Global Chief Marketing Officer Fuller Kevin Gregory was granted 13,148 shares, increasing direct ownership by 119% to 24,218 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      3/12/25 6:37:04 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • EVP & President, Europe Yates Bryant J covered exercise/tax liability with 1,201 shares and was granted 12,810 shares, increasing direct ownership by 12% to 108,908 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      3/12/25 6:36:54 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • VP, Human Resources Comstock Tracee was granted 8,890 shares and covered exercise/tax liability with 834 shares, increasing direct ownership by 14% to 65,684 units (SEC Form 4)

      4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

      3/12/25 6:36:44 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Nature's Sunshine Products Inc. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DA Davidson resumed coverage on Nature's Sunshine with a new price target

      DA Davidson resumed coverage of Nature's Sunshine with a rating of Buy and set a new price target of $19.00

      5/7/25 8:37:48 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Canaccord Genuity initiated coverage on Nature's Sunshine with a new price target

      Canaccord Genuity initiated coverage of Nature's Sunshine with a rating of Buy and set a new price target of $18.00

      9/13/24 7:38:59 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • DA Davidson reiterated coverage on Natures Sunshine Products with a new price target

      DA Davidson reiterated coverage of Natures Sunshine Products with a rating of Buy and set a new price target of $24.50 from $24.00 previously

      3/9/22 9:23:08 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • DA Davidson reiterated coverage on Natures Sunshine Products with a new price target

      DA Davidson reiterated coverage of Natures Sunshine Products with a rating of Buy and set a new price target of $24.00 from $22.00 previously

      11/5/21 8:43:55 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • DA Davidson initiated coverage on Natures Sunshine Products with a new price target

      DA Davidson initiated coverage of Natures Sunshine Products with a rating of Buy and set a new price target of $22.00

      10/15/21 4:37:55 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Nature's Sunshine Products Inc. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nature's Sunshine Reports Strong First Quarter 2025 Results

      LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 2% to $113.2 million compared to $111.0 million (up 5% in constant currency).GAAP net income attributable to common shareholders was up 104% to $4.7 million, or $0.25 per diluted common share, compared to $2.3 million, or $0.12 per diluted common share.Adjusted EBITDA was up 20% to $11.0 million compared to $9.2 million. Capital Allocation Na

      5/6/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Heidi Wissmiller as Chairman of the Board

      LEHI, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the appointment of Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. She succeeds Richard D. Moss, who has retired after serving as a Director since 2018 and Chairman since 2022. Ms. Wissmiller has served on the Board of Nature's Sunshine since 2020. Over the course of her tenure, she has chaired the Governance and Risk Management Committees. As Chief Growth Officer at Rodan + Fields ("R+F"), the leading skincare brand in North America, Ms. Wissmiller led

      5/5/25 8:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Wins Two Stevie® Awards in the 2025 American Business Awards®

      LEHI, Utah, April 24, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced it has been recognized with two prestigious Stevie® Awards in the 23rd Annual American Business Awards®. Nature's Sunshine received a Gold Stevie® Award for its 2023 Impact Report, which detailed the Company's achievements and progress in responsible business practices and sustainability. Additionally, the Company earned a Silver Stevie® Award for Achievement in Product Innovation for its new Chlorophyll Detoxifying Stick Packs. "We are deeply honored to be recognized by the American Business Awards," sai

      4/24/25 1:52:06 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Releases 2024 Impact Report Highlighting Environmental and Sustainability Achievements

      LEHI, Utah, April 24, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the publication of its 2024 Impact Report to share the Company's efforts around social responsibility and sustainability. The comprehensive report outlines Nature's Sunshine's substantial progress toward its environmental, social, and governance (ESG) goals, showcasing the Company's commitment to sustainability and responsible business practices. The report highlights Nature's Sunshine's progress toward its 2025 ESG goals, including: Receiving TRUE Zero Waste Gold Certification for its U.S. Distribution

      4/24/25 12:15:18 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Sets First Quarter 2025 Conference Call for Tuesday, May 6, 2025, at 5:00 p.m. ET

      LEHI, Utah, April 22, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, May 6, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2025. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, May 6, 2025Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)Toll-free di

      4/22/25 4:04:59 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Reports Fourth Quarter and Full Year 2024 Financial Results

      LEHI, Utah, March 11, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 8.5% to $118.2 million compared to $108.9 million (up 10.0% in constant currency).GAAP net loss attributable to common shareholders of $0.3 million, or $(0.02) per diluted share, compared to net income of $9.0 million, or $0.46 per diluted share.Adjusted EBITDA up 6% to $10.3 million com

      3/11/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Launches First Integrated Brand Platform

      LEHI, Utah, March 03, 2025 (GLOBE NEWSWIRE) -- Leading natural health and wellness company Nature's Sunshine announces today the launch of its new brand platform, "Be More Earth." In the brand's first integrated platform created in partnership with media and creative agency Crispin, the spotlight is on Nature's Sunshine's storied history of harnessing nature's healing powers and sharing it with consumers. The entire brand platform and visual design are inspired by the Earth – its uniqueness, natural beauty and restorative power – while honoring over 50 years of sourcing the finest ingredients it has to offer. "We believe that the Earth has the healing power that all customers deserve. Our

      3/3/25 2:36:06 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Sets Fourth Quarter and Full Year 2024 Conference Call for Tuesday, March 11, 2025, at 5:00 p.m. ET

      LEHI, Utah, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 11, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, March 11, 2025Time: 5:00 p.m. Eastern time (3:00 p.m.

      2/25/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Katie A. May to Board of Directors

      LEHI, Utah, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Ms. Katie A. May to its board of directors effective January 30, 2025. Nature's Sunshine's board will now consist of ten directors with nine serving as independent directors. "Katie brings significant experience scaling and leading high-growth B2C, ecommerce and logistics companies," said Richard D. Moss, Chairman of the Board of Nature's Sunshine. "Her deep understanding of the full ecommerce lifecycle will strengthen and enhance our digital capabilities and drive s

      2/5/25 4:05:00 PM ET
      $NATR
      $PBI
      $STMP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Office Equipment/Supplies/Services
      Miscellaneous
    • Nature's Sunshine Partners with Cirque Series to Push Peaks 2025-2027

      LEHI, Utah, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced a new partnership with Cirque Series, the premier mountain race series in the United States.   "We're honored to team up with this exciting organization as Title Sponsor, to champion athletes exemplifying resilience and strength," said Kevin Fuller, Global Chief Marketing Office of Nature's Sunshine. "Together we're committed to empowering people to live bigger, naturally—and to embrace the adventure of each mountain ahead."   Founded in 2015 by acclaimed skier Julian Carr, the Cirque S

      12/3/24 11:22:39 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Nature's Sunshine Products Inc. Leadership Updates

    Live Leadership Updates

    See more
    • Nature's Sunshine Appoints Heidi Wissmiller as Chairman of the Board

      LEHI, Utah, May 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the appointment of Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. She succeeds Richard D. Moss, who has retired after serving as a Director since 2018 and Chairman since 2022. Ms. Wissmiller has served on the Board of Nature's Sunshine since 2020. Over the course of her tenure, she has chaired the Governance and Risk Management Committees. As Chief Growth Officer at Rodan + Fields ("R+F"), the leading skincare brand in North America, Ms. Wissmiller led

      5/5/25 8:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Katie A. May to Board of Directors

      LEHI, Utah, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Ms. Katie A. May to its board of directors effective January 30, 2025. Nature's Sunshine's board will now consist of ten directors with nine serving as independent directors. "Katie brings significant experience scaling and leading high-growth B2C, ecommerce and logistics companies," said Richard D. Moss, Chairman of the Board of Nature's Sunshine. "Her deep understanding of the full ecommerce lifecycle will strengthen and enhance our digital capabilities and drive s

      2/5/25 4:05:00 PM ET
      $NATR
      $PBI
      $STMP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Office Equipment/Supplies/Services
      Miscellaneous
    • Nature's Sunshine Appoints Steven Fasching to Board of Directors

      LEHI, Utah, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Mr. Steven Fasching to its board of directors, effective November 6, 2024. Nature's Sunshine's board will now consist of nine directors with eight serving as independent directors. "We are delighted to welcome Steve to our expanded board of directors," said Richard D. Moss, Chairman of the Board for Nature's Sunshine. "He brings significant financial acumen and public company experience from well-known consumer brands and will be a valuable addition to our board. Ste

      11/11/24 4:05:00 PM ET
      $DECK
      $NATR
      Shoe Manufacturing
      Consumer Discretionary
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Names Kevin Fuller Global Chief Marketing Officer

      LEHI, Utah, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading manufacturer of high-quality herbal and nutritional supplements, today announced the appointment of Kevin Fuller as Global Chief Marketing Officer, effective September 23, 2024. Fuller, a seasoned marketing executive with over two decades of experience in high-performance organizations, brings in-depth global marketing experience to Nature's Sunshine. His deep understanding of the dietary supplement industry combined with his experience launching new products, building powerful brands, and driving customer growth strategies make Fuller an ideal fit for Nature's Sunshine. "We are ver

      9/16/24 2:00:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Announces Retirement of CFO Joseph Baty

      Jonathon Lanoy to Serve as Interim CFO LEHI, Utah, Sept. 6, 2022 /PRNewswire/ -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company of high-quality herbal and nutritional products, today announced the retirement from the company of its Chief Financial Officer Joseph Baty, effective September 30, 2022. Nature's Sunshine has engaged a leading executive search firm to find its next CFO. Jonathan Lanoy, the company's Corporate Controller and Vice President of Finance, will serve as interim CFO, principal financial offi

      9/6/22 5:00:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Martin Gonzalez as Executive Vice President of Global Supply Chain

      New leader brings 30 years of supply chain innovation and excellence to support global transformation LEHI, Utah, May 4, 2022 /PRNewswire/ -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) today announced that Martin Gonzalez has been appointed Executive Vice President of Global Supply Chain effective May 16, 2022. Mr. Gonzalez brings over 30 years of experience from such notable companies as Unilever, Molson Coors/SABMiller and Sara Lee. His success in leading positive transformations to deliver both savings and growth through supply chain improvements helped him stand out as

      5/4/22 10:05:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • NATURE'S SUNSHINE APPOINTS TRENT MCCAUSLAND AS VICE PRESIDENT OF GLOBAL SUSTAINABILITY & TRANSPARENCY

      LEHI, Utah, March 3, 2022 /PRNewswire/ -- Nature's Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company of premium-quality herbal and nutritional products, recently appointed Trent McCausland as Vice President of Global Sustainability & Transparency. This new role is part of Nature's Sunshine's commitment to sustainable improvements to its sourcing, manufacturing and other operations processes, which will be outlined in the company's inaugural sustainability report to be released in March 2022. As Vice President of Global Sustainability & Transparenc

      3/3/22 1:23:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • NATURE'S SUNSHINE APPOINTS TRENT MCCAUSLAND AS VICE PRESIDENT OF GLOBAL SUSTAINABILITY & TRANSPARENCY

      LEHI, Utah, Feb. 16, 2022 /PRNewswire/ -- Nature's Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company of premium-quality herbal and nutritional products, recently appointed Trent McCausland as Vice President of Global Sustainability & Transparency. This new role is part of Nature's Sunshine's commitment to sustainable improvements to its sourcing, manufacturing and other operations processes, which will be outlined in the company's inaugural sustainability report to be released in March 2022. As Vice President of Global Sustainability & Transparenc

      2/16/22 11:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • NATURE'S SUNSHINE APPOINTS VALLEN BLACKBURN AS VICE PRESIDENT AND GENERAL MANAGER OF LATIN AMERICA

      LEHI, Utah, Jan. 26, 2022 /PRNewswire/ -- Nature's Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company of premium-quality herbal and nutritional products, announced today that Vallen Blackburn has been appointed Vice President and General Manager of Latin America. Since joining Nature's Sunshine in July of 2016, Blackburn has used his experience in finance strategies to help build Nature's Sunshine's Synergy business and significantly develop its business intelligence strategies for the North America team.  Blackburn brought with him experience from

      1/26/22 11:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Appoints Curtis Kopf to Board of Directors

      LEHI, Utah, Jan. 4, 2022 /PRNewswire/ -- Nature's Sunshine Products, Inc. (Nature's Sunshine) (NASDAQ:NATR), a leading natural health and wellness company engaged in the manufacture and sale of nutritional and personal care products, has appointed Curtis Kopf to its board of directors effective January 1, 2022. Nature's Sunshine's board will now consist of ten directors with nine serving as independent directors. "Curtis is a proven executive with extensive experience in creating digital customer experiences for global brands," said Terrence Moorehead, President and CEO of Nat

      1/4/22 9:00:00 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Nature's Sunshine Products Inc. Financials

    Live finance-specific insights

    See more
    • Nature's Sunshine Reports Strong First Quarter 2025 Results

      LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 2% to $113.2 million compared to $111.0 million (up 5% in constant currency).GAAP net income attributable to common shareholders was up 104% to $4.7 million, or $0.25 per diluted common share, compared to $2.3 million, or $0.12 per diluted common share.Adjusted EBITDA was up 20% to $11.0 million compared to $9.2 million. Capital Allocation Na

      5/6/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Sets First Quarter 2025 Conference Call for Tuesday, May 6, 2025, at 5:00 p.m. ET

      LEHI, Utah, April 22, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, May 6, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2025. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, May 6, 2025Time: 5:00 p.m. Eastern time (3:00 p.m. Mountain time)Toll-free di

      4/22/25 4:04:59 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Reports Fourth Quarter and Full Year 2024 Financial Results

      LEHI, Utah, March 11, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 8.5% to $118.2 million compared to $108.9 million (up 10.0% in constant currency).GAAP net loss attributable to common shareholders of $0.3 million, or $(0.02) per diluted share, compared to net income of $9.0 million, or $0.46 per diluted share.Adjusted EBITDA up 6% to $10.3 million com

      3/11/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Sets Fourth Quarter and Full Year 2024 Conference Call for Tuesday, March 11, 2025, at 5:00 p.m. ET

      LEHI, Utah, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 11, 2025, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, March 11, 2025Time: 5:00 p.m. Eastern time (3:00 p.m.

      2/25/25 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Reports Third Quarter 2024 Results

      LEHI, Utah, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading natural health and wellness company offering high-quality herbal and nutritional products, reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 3% to $114.6 million compared to $111.2 million (up 4% in constant currency).GAAP net income attributable to common shareholders was $4.3 million, or $0.23 per diluted common share, compared to $2.8 million, or $0.15 per diluted common share.Adjusted EBITDA was up 5% to $10.7 million compared to $10.3 million. Management

      11/7/24 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Sets Third Quarter 2024 Conference Call for Thursday, November 7, 2024, at 5:00 p.m. ET

      LEHI, Utah, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company offering high-quality herbal and nutritional products, will conduct a conference call on Thursday, November 7, 2024, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the third quarter ended September 30, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Thursday, November 7, 2024Time: 5:00 p.m. Eastern t

      10/24/24 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Reports Second Quarter 2024 Results

      LEHI, Utah, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company of high-quality herbal and nutritional products, reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were down 5% to $110.6 million compared to $116.5 million (down 3% in constant currency).Gross margin decreased 125 basis points to 71.4% compared to 72.6%.GAAP net income attributable to common shareholders was $1.3 million, or $0.07 per diluted common share, compared to $2.4 million, or $0.12 per diluted common share.Adjusted EBITDA down

      8/8/24 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Sets Second Quarter 2024 Conference Call for Thursday, August 8, 2024, at 5:00 p.m. ET

      LEHI, Utah, July 25, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company offering high-quality herbal and nutritional products, will conduct a conference call on Thursday, August 8, 2024, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the second quarter ended June 30, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Thursday, August 8, 2024Time: 5:00 p.m. Easte

      7/25/24 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Reports Strong First Quarter 2024 Results

      LEHI, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company offering high-quality herbal and nutritional products, reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Summary vs. Same Year-Ago Quarter Net sales were up 2% to $111.0 million compared to $108.6 million (up 4% in constant currency).Gross margin increased 33 basis points to 71.2% compared to 70.8%.GAAP net income attributable to common shareholders up significantly to $2.3 million, or $0.12 per diluted common share, compared to $0.9 million, or $0.04 per diluted common share.Ad

      5/7/24 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Nature's Sunshine Sets First Quarter 2024 Conference Call for Tuesday, May 7, 2024, at 5:00 p.m. ET

      LEHI, Utah, April 23, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) (Nature's Sunshine), a leading natural health and wellness company of premium-quality herbal and nutritional products, will conduct a conference call on Tuesday, May 7, 2024, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2024. The company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Terrence Moorehead and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, May 7, 2024Time: 5:00 p.m. Eastern time (3:00 p.m. Mou

      4/23/24 4:05:00 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care

    Nature's Sunshine Products Inc. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/12/24 10:37:49 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      1/31/24 11:56:05 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/13/23 2:42:04 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/9/23 11:27:43 AM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/7/23 1:33:09 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/9/22 5:01:28 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/7/22 2:51:39 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13D/A filed by Nature's Sunshine Products, Inc. (Amendment)

      SC 13D/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      9/17/21 8:16:01 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form SC 13G/A filed

      SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

      2/10/21 4:06:01 PM ET
      $NATR
      Biotechnology: Pharmaceutical Preparations
      Health Care